Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. Miplyffa
BrandsMiplyffa

How AI describes Miplyffa

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

Miplyffa logoMiplyffamiplyffa.com

MIPLYFFA (arimoclomol) is a prescription medication used in combination with miglustat to treat neurological symptoms of Niemann-Pick disease type C (NPC) in patients aged 2 years and older. It is the only therapy shown to stop disease progression at 12 months for this condition.

Parse Score

31.8
Strength6/ 100
Reach25/ 100
Authority0/ 100

Work at Miplyffa?

Claim this profile for the full report: every prompt where Miplyffa appears, who is gaining, and what AI says about you. Claiming is free. Ongoing monitoring is a paid upgrade.

Verified with a work email.

Always know where you stand in AI

Monitor Miplyffa